|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 14299 |
FusionGeneSummary for GALNT13_USP34 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GALNT13_USP34 | Fusion gene ID: 14299 | Hgene | Tgene | Gene symbol | GALNT13 | USP34 | Gene ID | 117248 | 9736 |
| Gene name | polypeptide N-acetylgalactosaminyltransferase 15 | ubiquitin specific peptidase 34 | |
| Synonyms | GALNACT15|GALNT13|GALNT7|GALNTL2|PIH5|pp-GalNAc-T15 | - | |
| Cytomap | 3p25.1 | 2p15 | |
| Type of gene | protein-coding | protein-coding | |
| Description | polypeptide N-acetylgalactosaminyltransferase 15UDP-GalNAc transferase T15UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15UDP-N-acetyl-alpha-D-ga | ubiquitin carboxyl-terminal hydrolase 34deubiquitinating enzyme 34ubiquitin specific protease 34ubiquitin thioesterase 34ubiquitin thiolesterase 34ubiquitin-specific-processing protease 34 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q8IUC8 | Q70CQ2 | |
| Ensembl transtripts involved in fusion gene | ENST00000392825, ENST00000409237, ENST00000487047, | ENST00000398571, ENST00000472689, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 6 X 7 X 2=84 |
| # samples | 3 | 7 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/84*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GALNT13 [Title/Abstract] AND USP34 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | USP34 | GO:0016579 | protein deubiquitination | 14715245 |
| Tgene | USP34 | GO:0071108 | protein K48-linked deubiquitination | 21383061 |
| Tgene | USP34 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 21383061 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | Z97017 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000392825 | ENST00000398571 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| intron-intron | ENST00000392825 | ENST00000472689 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| intron-intron | ENST00000409237 | ENST00000398571 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| intron-intron | ENST00000409237 | ENST00000472689 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| intron-intron | ENST00000487047 | ENST00000398571 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
| intron-intron | ENST00000487047 | ENST00000472689 | GALNT13 | chr2 | 155153258 | - | USP34 | chr2 | 61479516 | + |
Top |
FusionProtFeatures for GALNT13_USP34 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GALNT13 | USP34 |
| Catalyzes the initial reaction in O-linkedoligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on theprotein receptor. Has a much stronger activity than GALNT1 totransfer GalNAc to mucin peptides, such as Muc5Ac and Muc7. Ableto glycosylate SDC3. May be responsible for the synthesis of Tnantigen in neuronal cells. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GALNT13_USP34 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GALNT13_USP34 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GALNT13_USP34 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GALNT13_USP34 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|